期刊文献+

基质金属蛋白酶-9在上皮性卵巢癌中的表达 被引量:4

原文传递
导出
摘要 目的:检测基质金属蛋白酶-9(MMP-9)在上皮性卵巢癌中的表达。方法:应用S-P法检测MMP-9在15例正常卵巢组织中及95例上皮性卵巢癌组织中的表达情况。结果:MMP-9在正常卵巢组织中低表达(阳性率26.67%),而在上皮性卵巢癌组织中高表达(阳性率82.10%),差异有统计学意义(P<0.05)。MMP-9阳性表达与上皮性卵巢癌组织学类型无关,差异无统计学意义(P>0.05);而与肿瘤大小、癌组织分化程度、临床分期及淋巴结转移有关,差异有统计学意义(P<0.05)。结论:MMP-9参与并促进了上皮性卵巢癌的发生、发展,可作为临床判断上皮性卵巢癌病变程度及预后的重要参考指标。
出处 《中国妇幼保健》 CAS 北大核心 2014年第7期1104-1106,共3页 Maternal and Child Health Care of China
  • 相关文献

参考文献5

二级参考文献29

  • 1Lin Li, Shao-Hua Chen, Yu Zhang, Chao-Hui Yu, Shu-Dan Li and You-Ming Li Department of Gastroenterology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.Is the hypoxia-inducible factor-1 alpha mRNA expression activated by ethanol-induced injury, the mechanism underlying alcoholic liver disease?[J].Hepatobiliary & Pancreatic Diseases International,2006,5(4):560-563. 被引量:8
  • 2赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 3尧良清,丰有吉,丁景新,徐丛剑,金鸿雁,殷莲华.缺氧诱导卵巢上皮性癌细胞形成拟态血管的前期研究[J].中华妇产科杂志,2005,40(10):662-665. 被引量:27
  • 4谷化平,冯和平,徐志勇,苏红.免疫组化在恶性黑色素瘤诊断中的作用[J].中国肿瘤临床,1996,23(8):599-600. 被引量:4
  • 5Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression[J].Nat Rev Cancer, 2002, 2 (3) : 161.
  • 6Paganoni P, Manenti L. Matrix ( MMP - 9 and MMP - 2) induce the release of vascular metalloproteinases endothelial growth factor (VEGF) by ovarian carcinoma ceils: implications for ascites formation [ J] . Cancer Res, 2003, 63 (17): 5224.
  • 7Murthi P, Barker G, Nowell C J, et al. Plasminogen fragmentation and increased production of extracellular matrix degrading proteinase are associated with serous epithelial ovarian progression [J]. Gynecol Oncol, 2004, 92 (1): 80.
  • 8Demeter A, Szirmai K, Olah J, et al. Elevated expression of matrix metalloptroteinase -9 and fibronectin concentration in recurrent epitheli- al ovarian cancer [J]. Orv Hetil, 2004, 145 (31) : 1617.
  • 9Sakata K, Shigenmasa K, Uebaba Y, et al. Expression of matrix metal- loproteinases - 2 and 9 by cells isolated from the peritoneal fluid of women with ovarian carcinoma [J]. Acta Cytol, 2002, 46 (4) : 697.
  • 10Weidner N, Gasparini G. Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients [J]. Breast Cancer Res Treat, 1994, 29 (1): 97.

共引文献1377

同被引文献45

  • 1万里,郑旭琴.SATB1在甲状腺癌中的表达及促进甲状腺癌侵袭能力的实验研究[J].中国生化药物杂志,2014,34(6):17-20. 被引量:18
  • 2杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 3王鑫,吕杰强,朱雪琼.胰岛素样生长因子系统在上皮性卵巢癌中的研究进展[J].国外医学(妇产科学分册),2006,33(4):256-259. 被引量:1
  • 4卢圣爱,陈自平,刘倩.胰岛素样生长因子-Ⅱ与肿瘤关系的研究进展[J].医学综述,2006,12(20):1249-1251. 被引量:4
  • 5Ziegler RG, Anderson WF, Gail MH. Increasing breast cancer incidence in China: the numbers add up (J:. J Natl Cancer Inst, ,'2008, 100 (19): 1339-1341.
  • 6Logsdon CD, Fuentes MK, Huang EH, et al. RAGE and RAGE ligands in cancer [ J]. Curr Mol Med, 2007, 7 (8) : 777-789.
  • 7Radia AM, Yaser AM, Ma X, et al. Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines ( J l- Int J Mol Sci, 2013, 14 (4) : 7959-7978.
  • 8Zhu P, Ren M, Yang C, et al. Involvement of RAGE, MAPK and NF-:B pathways in ages-induced MMP-9 activation in HaCaT keratinocytes [ J ]. Exp Dermatol, 2012, 21 ( 2 ) : 123-129.
  • 9Zhang L, Bukulin M, Kojro E, et al. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases [ J 3- J Biol Chem, 2008, 283 (51) : 35507-35516.
  • 10Zhang J, Zhu JS, Zhou Z, et al. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1- RAGE and Akt pathways in vitro and in vivo :J3. Oncol Rep, 2012, 27 (5) : 1511-1519.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部